XML 58 R44.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Earnings Per Common Share (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Earnings Per Share [Abstract] |
Computation of Basic and Diluted Earnings per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Basic: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 517.6 |  |  | $ | 368.8 |  |  | $ | 446.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (105.0) |  |  | (84.6) |  |  | (87.1) |
Less: Income allocated to participating securities | (1.8) |  |  | (1.0) |  |  | (1.3) |
Income from continuing operations attributable to Encompass Health common shareholders | 410.8 |  |  | 283.2 |  |  | 358.0 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.4) |  |  | — |  |  | (0.6) |
Net income attributable to Encompass Health common shareholders | $ | 410.4 |  |  | $ | 283.2 |  |  | $ | 357.4 |
Denominator: |  |  |  |  |
Basic weighted average common shares outstanding | 99.0 |  |  | 98.6 |  |  | 98.0 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |
Continuing operations | $ | 4.15 |  |  | $ | 2.87 |  |  | $ | 3.66 |
Discontinued operations | — |  |  | — |  |  | (0.01) |
Net income | $ | 4.15 |  |  | $ | 2.87 |  |  | $ | 3.65 |
Diluted: |  |  |  |  |
Numerator: |  |  |  |  |
Income from continuing operations | $ | 517.6 |  |  | $ | 368.8 |  |  | $ | 446.4 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (105.0) |  |  | (84.6) |  |  | (87.1) |
Income from continuing operations attributable to Encompass Health common shareholders | 412.6 |  |  | 284.2 |  |  | 359.3 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | (0.4) |  |  | — |  |  | (0.6) |
Net income attributable to Encompass Health common shareholders | $ | 412.2 |  |  | $ | 284.2 |  |  | $ | 358.7 |
Denominator: |  |  |  |  |
Diluted weighted average common shares outstanding | 100.2 |  |  | 99.8 |  |  | 99.4 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |
Continuing operations | $ | 4.11 |  |  | $ | 2.85 |  |  | $ | 3.62 |
Discontinued operations | — |  |  | — |  |  | (0.01) |
Net income | $ | 4.11 |  |  | $ | 2.85 |  |  | $ | 3.61 |
Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| For the Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Basic weighted average common shares outstanding | 99.0 |  |  | 98.6 |  |  | 98.0 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.2 |  |  | 1.2 |  |  | 1.4 |
Diluted weighted average common shares outstanding | 100.2 |  |  | 99.8 |  |  | 99.4 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration